# Benign Familial Infantile Seizures (BFIS)

Benign Familial Infantile Seizures — also known as **self-limited familial infantile epilepsy** — is one of the most clearly established PRRT2-related conditions. Its name reflects its three defining features: it appears in **families**, it begins in **infancy**, and it is **benign** — meaning it resolves on its own and does not affect long-term development.

## What an episode looks like

BFIS seizures usually begin in the first year of life, most often between the **third and twelfth month**. They are typically **focal seizures** — meaning they begin in one part of the brain and can sometimes spread. A child may briefly stop responding, stare, twitch on one side, or have brief generalized movements. Episodes tend to come in **clusters**, sometimes several over a few hours or days, then settle.

Even with multiple seizures, the child's development typically continues normally, and most children do not experience seizures beyond about **age two or three**.

## Why "benign"

The word *benign* in medicine means that, despite the alarming appearance of seizures in a small child, this form of infantile epilepsy carries a **good long-term outlook**. Children with BFIS generally develop normally, outgrow the seizures within a few years, and reach normal milestones.

That word is a relief for families. But it is also part of why BFIS used to be under-recognized: a "benign" condition that resolves on its own can be set aside as a one-off, without anyone realizing it is one expression of an inherited PRRT2 variant that may surface differently in other family members later in life.

## The connection to PKD

BFIS often appears in the same families — and even the same individuals — as **paroxysmal kinesigenic dyskinesia (PKD)**, which typically begins in childhood or adolescence. When one person has both, the combination has a specific name: **infantile convulsions with choreoathetosis (ICCA)**.

A child who had infantile seizures and later begins experiencing brief, movement-triggered episodes in childhood is, in many cases, moving along the same PRRT2 spectrum from one phenotype to another. (See [The PRRT2 Spectrum](/associated-conditions/prrt2-spectrum.md) for how the conditions relate.)

## Treatment and recognition

BFIS typically **responds well to standard anti-seizure medications** — including sodium-channel-blocking drugs such as carbamazepine — although many children outgrow the seizures with or without medication. Specifics are covered in [Treatments & Management](/treatments-and-management/how-treatment-works.md).

The more important thing for families is **recognition**. Because BFIS resolves on its own, families and clinicians may never connect it to anything else — until years later, when a relative develops PKD or hemiplegic migraine, and someone finally puts the pieces together. Genetic testing now lets that recognition happen sooner.

{% hint style="success" %}
**🧭 PRRT2.org Perspective**

*PRRT2.org's own perspective — our synthesis and lived experience, offered alongside the established science, not as established medical fact.*

A "benign" diagnosis that resolves in early childhood is good news in the moment — but it can leave a family without the information they need years later, when another symptom appears in the same person, or in a sibling or a cousin.

PRRT2.org's view is that an infantile seizure history is an important clue worth keeping in the record, even when the seizures themselves resolve. If you or your child had unexplained seizures in infancy and another family member later developed unexplained paroxysmal episodes, PRRT2 is worth asking about. The thread can run quietly for a generation before anyone sees it.
{% endhint %}

## Sources

The established science on this page is drawn from:

* [MedlinePlus Genetics — PRRT2 gene](https://medlineplus.gov/genetics/gene/prrt2/) — U.S. National Library of Medicine, NIH
* [GeneReviews — Familial Paroxysmal Kinesigenic Dyskinesia](https://www.ncbi.nlm.nih.gov/books/NBK1460/) — University of Washington / NCBI
* [OMIM — Entry 614386](https://omim.org/entry/614386) — Johns Hopkins University

For the complete set of authoritative references, see [Official Resources](/resources/official-resources.md).

## Continue reading

* [Paroxysmal Kinesigenic Dyskinesia (PKD)](/associated-conditions/pkd.md) — the movement-disorder part of the spectrum
* [Inheritance & Genetics](/prrt2-gene-overview/inheritance-and-genetics.md) — how PRRT2 moves through families
* [How to Get Tested](/diagnosis-and-genetic-testing/how-to-get-tested.md) — pursuing a genetic diagnosis


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://www.prrt2.org/associated-conditions/bfis.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.